BioSpace News Archive

Genetown

Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024

Aura Biosciences, Inc., a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, announced that it will host a virtual KOL event on Wednesday, May 29, 2024 at 2:00 PM ET.

May 23, 2024
·
7 min read
BioForest

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Nautilus Biotechnology, Inc. today announced the company will be participating in the Goldman Sachs 45th Annual Healthcare Conference.

May 23, 2024
·
1 min read
Biotech Beach

GeneType and Humanise Health host “Know Your Risk” Event

Genetic Technologies Limited is pleased to announce that the Know Your Risk event held yesterday at The Langham Pasadena has set a new standard for women’s health initiatives, highlighting the transformative potential of genetic testing and risk assessment.

May 23, 2024
·
5 min read
Business

Novo Holdings Boston office named a 2024 Best Place to Work by the Boston Business Journal

Novo Holdings, a leading life science investor, announced that its Boston office has been named a 2024 Best Place to Work by the Boston Business Journal.

May 23, 2024
·
2 min read
Biotech Bay

Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors

Radar Therapeutics today announced the completion of an oversubscribed $13.4 million in seed financing led by NfX Bio.

May 23, 2024
·
4 min read
Genetown

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

Astria Therapeutics, Inc. today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.

May 23, 2024
·
1 min read
BioForest

Indapta Therapeutics to Highlight its g-NK Cell Platform for the Treatment of Cancer and Autoimmune Disease in a Plenary Session at New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference

Indapta Therapeutics, Inc. announced that CEO Mark Frohlich, MD, will be giving a plenary talk today titled, “g-NK cells for the treatment of cancer and autoimmune disease” at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference.

May 23, 2024
·
3 min read
Pharm Country

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

Neuronetics, Inc. today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Thursday, June 6, 2024.

May 23, 2024
·
1 min read
Genetown

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label

Yield10 Bioscience, Inc. today announced that UPL Ltd. (“UPL”) has received U.S. Environmental Protection Agency (“EPA”) approval to amend the label language of INTERLINE ® Herbicide to include the oilseed Camelina sativa (“Camelina”).

May 23, 2024
·
4 min read
Biotech Bay

Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit

Allogene Therapeutics, Inc. today announced it will participate in the TD Cowen 5th Annual Oncology Innovation Summit.

May 23, 2024
·
2 min read